This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
ST-elevation Myocardial Infarction
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

A prospective, randomized, controlled multi-site feasibility trial to assess the potential role of the IMPELLA® 2.5 System in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI)

Provided treatments

  • Device: Impella 2.5 support
  • Other: Standard of care (Control)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01319760. The sponsor of the trial is Abiomed Inc. and it is looking for 5 volunteers for the current phase.
Official trial title:
MINI-AMI: Minimizing INfarct Size With IMPELLA® 2.5 System Following PCI for Acute Myocardial Infarction